Article
Patient-Derived iPSC-Cardiomyocytes Reveal Subclinical Cardiomyocyte Dysfunction Associated With the CAV3 N-Terminal Variant p.Ala46Thr.
Human mutation - 1 Jan 2026
Wang Junyi, Zhu Xintong, Li Yaqiong, Dai Limeng, Tan Xiaoyin, Li Jia, Guo Hong
Abstract excerpt
The CAV3 p.Ala46Thr mutation is previously associated with skeletal muscle damage only, with its myocardial impact and long-term cardiac risks unclear. This study is aimed at investigating whether it induces subclinical myocardial damage at the cellular level and explore its mechanism using a patient-specific iPSC-CMs model. To achieve this, peripheral blood from a proband carrying the CAV3 c.136G>A (p.Ala46Thr)...
Read the complete abstract on PubMedTopics
- Humans
- Myocytes, Cardiac
- Induced Pluripotent Stem Cells
- Caveolin 3
- Mutation
- Cell Differentiation
